Cerenome (PSTV) Goodwill & Intangibles (2010 - 2026)
Plus Therapeutics (PSTV) posted quarterly Goodwill & Intangibles of $671000.0 for Q1 2026, down 16.85% year-over-year from $807000.0 in Q1 2025, and down 4.82% quarter-over-quarter from $705000.0 in Q4 2025.
Cerenome (PSTV) Goodwill & Intangibles (2010 - 2026) Analysis & Trends
Plus Therapeutics (PSTV) has reported Goodwill & Intangibles for 17 consecutive years, with $671000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Goodwill & Intangibles fell 16.85% year-over-year to $671000.0; the TTM figure through Mar 2026 stood at $671000.0 (down 16.85% YoY), while the FY2025 annual figure was $705000.0, up 50.32% from the prior year.
- Goodwill & Intangibles eased to $671000.0 in Q1 2026 per PSTV's latest filing, from $705000.0 in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $929000.0 in Q2 2024 and bottomed at $405000.0 in Q1 2024.
- Historically, Goodwill & Intangibles has averaged $593411.8 across 5 years, with a median of $503000.0 in 2022.
- Annual changes were most pronounced in 2024 — Goodwill & Intangibles jumped 113.07% — and 2026, when it slipped 16.85%.
- Plus Therapeutics' Goodwill & Intangibles stood at $466000.0 in 2022, then declined by 11.16% to $414000.0 in 2023, then climbed by 13.29% to $469000.0 in 2024, then surged by 50.32% to $705000.0 in 2025, then retreated by 4.82% to $671000.0 in 2026.
- Business Quant data shows PSTV's Goodwill & Intangibles at $671000.0 in Q1 2026, $705000.0 in Q4 2025, and $746000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cerenome | 28.07 Mn | 19.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 671,000.00 |
| Dec 31, 2025 | 705,000.00 |
| Sep 30, 2025 | 746,000.00 |
| Jun 30, 2025 | 773,000.00 |
| Mar 31, 2025 | 807,000.00 |
| Dec 31, 2024 | 469,000.00 |
| Sep 30, 2024 | 885,000.00 |
| Jun 30, 2024 | 929,000.00 |
| Mar 31, 2024 | 405,000.00 |
| Dec 31, 2023 | 414,000.00 |
| Sep 30, 2023 | 421,000.00 |
| Jun 30, 2023 | 436,000.00 |
| Mar 31, 2023 | 451,000.00 |
| Dec 31, 2022 | 466,000.00 |
| Sep 30, 2022 | 485,000.00 |
| Jun 30, 2022 | 503,000.00 |
| Mar 31, 2022 | 522,000.00 |
| Dec 31, 2021 | 423,000.00 |
| Sep 30, 2021 | 432,000.00 |
| Jun 30, 2021 | 441,000.00 |